The number of women who end up in an ENT office, get told nothing is structurally wrong, and are sent home without answers is genuinely heartbreaking. Vertigo feels like a neurological emergency, not a hormone symptom — and that disconnect means women wait months for an explanation that should have come on day one.
Learn more about Rose →Estrogen receptors — specifically ERα and ERβ — have been identified throughout the inner ear structures, including the cochlea, the endolymphatic sac, and the semicircular canals. This means the vestibular system is not merely adjacent to hormonal change; it is a direct hormonal target. When estrogen levels fluctuate or decline during perimenopause, the inner ear is responding to that in real time, not as a side effect but as a primary physiological event.
The inner ear is filled with a fluid called endolymph, and maintaining its precise ionic composition is essential for accurate balance signalling. Estrogen plays a documented role in regulating the ion transport mechanisms — particularly sodium and potassium channels — that keep endolymph in balance. When estrogen drops, fluid homeostasis in the inner ear can be disrupted, creating conditions that mimic or trigger Ménière's-like symptoms including vertigo, ear fullness, and fluctuating hearing.
Benign Paroxysmal Positional Vertigo — the most common cause of vertigo worldwide — shows a striking epidemiological peak in women between the ages of 40 and 60, which maps almost precisely onto the perimenopause and early postmenopause window. BPPV occurs when calcium carbonate crystals called otoconia dislodge from their membrane and migrate into the semicircular canals. Research suggests that declining estrogen may accelerate otoconia degradation and increase the likelihood of dislodgement, making women during this transition disproportionately vulnerable.
Otoconia, the tiny crystals at the root of BPPV, are composed primarily of calcium carbonate and require a stable calcium metabolism to maintain their structural integrity. As estrogen declines, calcium metabolism shifts — the same mechanism driving bone density loss — and this appears to affect otoconia quality and adherence. Women with lower bone mineral density have been found in multiple studies to have significantly higher rates of BPPV, suggesting that the skeletal and vestibular systems share a common hormonal vulnerability.
Progesterone, and particularly its neurosteroid metabolite allopregnanolone, acts on GABA-A receptors throughout the central nervous system, including pathways involved in vestibular processing and motion perception. As progesterone drops in perimenopause — often before estrogen does — the vestibular system may become hypersensitive, meaning ordinary head movement or sensory input is processed as disproportionately destabilising. This may explain why some women report a persistent sense of unsteadiness or motion sensitivity even when no structural inner ear problem can be found.
Hot flashes and night sweats are driven by sudden shifts in core body temperature and vascular tone — and the inner ear's blood supply is particularly sensitive to vascular changes. A vasomotor episode can briefly alter blood flow to the labyrinthine artery, which is the sole blood supply to the inner ear, potentially triggering transient vertigo or dizziness as part of the same autonomic cascade. Women who experience frequent and severe hot flashes report correspondingly higher rates of dizziness, and the two symptoms often cluster together in diaries and symptom logs.
The vestibular system's ability to process and recalibrate balance signals is partly dependent on adequate sleep, during which the brain consolidates sensory information and resets postural control circuits. Perimenopause-related sleep disruption — driven by night sweats, anxiety, and hormonal fluctuation — chronically deprives the brain of this recalibration window. Women who are significantly sleep deprived show measurably worse postural stability on balance testing, meaning poor sleep and vestibular dysfunction create a mutually reinforcing cycle that is hard to break without addressing both.
The vestibular system and the brain's threat-detection networks — including the amygdala and the locus coeruleus — are bidirectionally connected, meaning anxiety can cause or amplify vestibular symptoms, and vestibular symptoms can drive anxiety. Perimenopausal anxiety, which is itself partly driven by progesterone and estrogen fluctuation, can therefore directly worsen perceived dizziness and balance difficulty. This two-way circuit is the mechanism behind Persistent Postural-Perceptual Dizziness (PPPD), a functional vestibular disorder that disproportionately affects women in midlife and is frequently missed in standard ENT workups.
Standard vestibular evaluations — including videonystagmography, caloric testing, and rotary chair assessments — were developed without any reference to hormonal status, meaning a perimenopausal woman can have entirely normal test results while experiencing genuinely disabling vestibular symptoms. Without a hormone-aware framework, clinicians often discharge these women with a reassurance that nothing is wrong, when in fact the problem is systemic and hormonally mediated. Advocating for a full symptom picture that includes menstrual history, vasomotor symptoms, and sleep quality is a reasonable and evidence-supported request when standard tests come back clear.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.